Indications and utility of allergen provocation testing;Indicaciones y rentabilidad de la provocación con alergenos

Allergologia et Immunopathologia

Volumn 32, Issue 3, 2004, Pages 129-133

  Sierra Martinez J I ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Allergens; Asthma; Bronchial hyperreactivity; Bronchial provocation tests; Carbon monoxide; Expired nitric oxide; Impulse oscillometry; Markers of inflammation; Recombinant allergens; Specific immunotherapy; Spirometry

Indexed keywords

ALLERGEN; CARBON MONOXIDE; IMMUNOMODULATING AGENT; NITRIC OXIDE;

ASTHMA; BRONCHOSPASM; BRONCHUS REACTIVITY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DOSE RESPONSE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; PROVOCATION TEST; RELIABILITY; REPRODUCIBILITY; SPIROMETRY; TREATMENT OUTCOME;

EID: 2542427603     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1157/13060596     Document Type: Conference Paper

References (16)

1. Colás C, En Facetas inéditas en asma bronquial. Publicación MSD, Madrid: Editores Médicos, S.A. 2000.
2. Prieto L, Gutiérrez V, Bertó JM. Pruebas de provocación bronquial con alergenos en el asma. Aspectos controvertidos Rev Esp Alergol Immunol Clin 1998;12:(Núm Extr.)84-96.
3. Arshad SH. Bronchial allergen challenge: a model for chronic allergic asthma? Clin Exp Allergy 1999;30:12-5.
4. Vives R, Hinojosa M, Cisteró AM. Pruebas de provocación bronquial específicas. En SEAIC (Eds). Pruebas de provocación bronquial inespecíficas y específicas. Madrid: Edicomplet, 1983; p. 87-109.
5. Spector SL. Allergen inhalatacion challenges: En Spector S.L. (Eds) Provocation testing in clinical practice. New York: Marcel Dekker, 1995; p. 325-36.
6. Ibre E, Axelsson I, Zetterstrom O. Late asthmatic reactions and bronchial variability after challenge with low doses of allergens. Clin Allergy 1988;18:557-67.
7. Spector SL. Allergen inhalatacion challenges: En Spector S.L. (Eds) Provocation testing in clinical practice. New York: Marcel Dekker, 1995; p. 328-36.
8. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995;151:1894-9.
9. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease Am J Respir Crit Care Med 2001;163(7):1693-722.
10. Sumitra BK, Ozkan M, Mccarthy K, Laskowski D, Hammel J, Raed DA, Serpil CE. Alterations in exhaled gas profile during allergen. Induced asthmatic response Am J Respir Crit Care Med 2001;164:1844-8.
11. Van Hage-Amsten M, Pauli G. Provocation testing with recombinant allergens. Methods, 2004; p. 281-91.
12. Cockroft DW, Ruffin RE, Hargreave FE. Appareance of allergen-induced increases in airway responsiveness only after repeated allergen inhalation in two subjects. Clin Exp Allergy 1993;23:225-7.
13. Phagoo SB, Watson RA, Pride NB, Silverman M. Accuracy and sensivity of the interrupter technique for measuring the response to bronchial challenge in normal subjets. Eur Respir J 1993;6:996-1003.
14. WHO Position Paper. Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(Suppl 44):5-42.
15. Muñoz-López F. Alergia respiratoria en la infancia y adolescencia. Barcelona: Springer-Verlag Ibérica, 1999.
16. Alvarez MJ, Echechipía B, García A, Tabar Al. Martín P, Rico P, Olaguibel JM. Liposome-entrapped D. pteronyssinus vaccination in mild asthma patients: effect of 1-year double-blind, placebo-controlled trial on inflammation, bronchial hyperresponsiveness and immediate and late bronchial responses to the allergen, Clin Exp Allergy 2002;32:1574-82.